|
1
|
Ivanova N, Dobrin R, Lu R, Kotenko I,
Levorse J, DeCoste C, Schafer X, Lun Y and Lemischka IR: Dissecting
self-renewal in stem cells with RNA interference. Nature.
442:533–538. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang J, Rao S, Chu J, Shen X, Levasseur
DN, Theunissen TW and Orkin SH: A protein interaction network for
pluripotency of embryonic stem cells. Nature. 444:364–368. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boumahdi S, Driessens G, Lapouge G, Rorive
S, Nassar D, Le Mercier M, Delatte B, Caauwe A, Lenglez S, Nkusi E,
et al: SOX2 controls tumour initiation and cancer stem-cell
functions in squamous-cell carcinoma. Nature. 511:246–250. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Power DG, Kelsen DP and Shah MA: Advanced
gastric cancer - slow but steady progress. Cancer Treat Rev.
36:384–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koyama-Nasu R, Haruta R, Nasu-Nishimura Y,
Taniue K, Katou Y, Shirahige K, Todo T, Ino Y, Mukasa A, Saito N,
et al: The pleiotrophin-ALK axis is required for tumorigenicity of
glioblastoma stem cells. Oncogene. 33:2236–2244. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Neumann J, Bahr F, Horst D, Kriegl L,
Engel J, Luque RM, Gerhard M, Kirchner T and Jung A: SOX2
expression correlates with lymph-node metastases and distant spread
in right-sided colon cancer. BMC Cancer. 11:5182011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Drilon A, Rekhtman N, Ladanyi M and Paik
P: Squamous-cell carcinomas of the lung: Emerging biology,
controversies, and the promise of targeted therapy. Lancet Oncol.
13:e418–e426. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lengerke C, Fehm T, Kurth R, Neubauer H,
Scheble V, Müller F, Schneider F, Petersen K, Wallwiener D, Kanz L,
et al: Expression of the embryonic stem cell marker SOX2 in
early-stage breast carcinoma. BMC Cancer. 11:422011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Du L, Yang Y, Xiao X, Wang C, Zhang X,
Wang L, Zhang X, Li W, Zheng G, Wang S and Dong Z: SOX2 nuclear
expression is closely associated with poor prognosis in patients
with histologically node-negative oral tongue squamous cell
carcinoma. Oral Oncol. 47:709–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Michifuri Y, Hirohashi Y, Torigoe T,
Miyazaki A, Kobayashi J, Sasaki T, Fujino J, Asanuma H, Tamura Y,
Nakamori K, et al: High expression of ALDH1 and SOX2 diffuse
staining pattern of oral squamous cell carcinomas correlates to
lymph node metastasis. Pathol Int. 62:684–689. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bray F, Ren JS, Masuyer E and Ferlay J:
Global estimates of cancer prevalence for 27 sites in the adult
population in 2008. Int J Cancer. 132:1133–1145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ren ZH, Wu HJ, Zhang S, Wang K, Gong ZJ,
He ZJ and Peng J: A new surgical strategy for treatment of tongue
squamous cell carcinoma based on anatomic study with preliminary
clinical evaluation. J Craniomaxillofac Surg. 43:1577–1582. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ren ZH, Wu HJ, Wang K, Zhang S, Tan HY and
Gong ZJ: Anterolateral thigh myocutaneous flaps as the preferred
flaps for reconstruction of oral and maxillofacial defects. J
Craniomaxillofac Surg. 42:1583–1589. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brinkman BM and Wong DT: Disease mechanism
and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol.
18:228–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo BH, Feng Y, Zhang R, Xu LH, Li MZ,
Kung HF, Song LB and Zeng MS: Bmi-1 promotes invasion and
metastasis, and its elevated expression is correlated with an
advanced stage of breast cancer. Mol Cancer. 10:102011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ren ZH and Wu HJ: Extracapsular spread in
cervical lymph nodes. Shiyong Kou Qiang Yi Xue Za Zhi. 28:514–517.
2012.(In Chinese).
|
|
17
|
El-Naaj IA, Leiser Y, Shveis M, Sabo E and
Peled M: Incidence of oral cancer occult metastasis and survival of
T1-T2N0 oral cancer patients. J Oral Maxillofac Surg. 69:2674–2679.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bass AJ, Watanabe H, Mermel CH, Yu S,
Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, et
al: SOX2 is an amplified lineage-survival oncogene in lung and
esophageal squamous cell carcinomas. Nat Genet. 41:1238–1242. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kitamura H, Torigoe T, Hirohashi Y,
Asanuma H, Inoue R, Nishida S, Tanaka T, Fukuta F, Masumori N, Sato
N and Tsukamoto T: Prognostic impact of the expression of ALDH1 and
SOX2 in urothelial cancer of the upper urinary tract. Mod Pathol.
26:117–124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Teodorczyk M, Kleber S, Wollny D, Sefrin
JP, Aykut B, Mateos A, Herhaus P, Sancho-Martinez I, Hill O,
Gieffers C, et al: CD95 promotes metastatic spread via Sck in
pancreatic ductal adenocarcinoma. Cell Death Differ. 22:1192–1202.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goel HL, Gritsko T, Pursell B, Chang C,
Shultz LD, Greiner DL, Norum JH, Toftgard R, Shaw LM and Mercurio
AM: Regulated splicing of the α6 integrin cytoplasmic domain
determines the fate of breastcancer stem cells. Cell Rep.
7:747–761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pardal R, Clarke MF and Morrison SJ:
Applying the principles of stem-cell biology to cancer. Nat Rev
Cancer. 3:895–902. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
González-Moles MA, Scully C, Ruiz-Ávila I
and Plaza-Campillo JJ: The cancer stem cell hypothesis applied to
oral carcinoma. Oral Oncol. 49:738–746. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boman BM and Wicha MS: Cancer stem cells:
A step toward the cure. J Clin Oncol. 26:2795–2799. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hahn WC and Weinberg RA: Rules for making
human tumor cells. N Engl J Med. 347:1593–1603. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wagers AJ and Weissman IL: Plasticity of
adult stem cells. Cell. 116:639–648. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Houghton J, Stoicov C, Nomura S, Rogers
AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR and Wang TC:
Gastric cancer originating from bone marrow-derived cells. Science.
306:1568–1571. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu AJ and Watt FM: Beta-catenin
signalling modulates proliferative potential of human epidermal
keratinocytes independently of intercellular adhesion. Development.
126:2285–2298. 1999.PubMed/NCBI
|
|
30
|
Cheng Y, Cheung AK, Ko JM, Phoon YP, Chiu
PM, Lo PH, Waterman ML and Lung ML: Physiological β-catenin
signaling controls self-renewal networks and generation of
stem-like cells from nasopharyngeal carcinoma. BMC Cell Biol.
14:442013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Morel AP, Lièvre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Z, Filho MS and Nör JE: The biology
of head and neck cancer stem cells. Oral Oncol. 48:1–9. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
González-Moles MA, Bravo M, Ruiz-Avila I,
Acebal F, Gil-Montoya JA, Brener S and Esteban F: Ki-67 expression
in non-tumour epithelium adjacent to oral cancer as risk marker for
multiple oral tumours. Oral Dis. 16:68–75. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu S, Zhang R, Liu F, Wang H, Wu J and
Wang Y: Notch inhibition suppresses nasopharyngeal carcinoma by
depleting cancer stem-like side population cells. Oncol Rep.
28:561–566. 2012.PubMed/NCBI
|
|
35
|
Zhang P, Zhang Y, Mao L, Zhang Z and Chen
W: Side population in oral squamous cell carcinoma possesses tumor
stem cell phenotypes. Cancer Lett. 277:227–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Song J, Chang I, Chen Z, Kang M and Wang
CY: Characterization of side populations in HNSCC Highly invasive,
chemoresistant and abnormal Wnt signaling. PLoS One. 5:e114562010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yanamoto S, Kawasaki G, Yamada S,
Yoshitomi I, Kawano T, Yonezawa H, Rokutanda S, Naruse T and Umeda
M: Isolation and characterization of cancer stem-like side
population cells in human oral cancer cells. Oral Oncol.
47:855–860. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Richard V, Nair MG, Santhosh Kumar TR and
Pillai MR: Side population cells as prototype of chemoresistant,
tumor-initiating cells. Biomed Res Int. 2013:5172372013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhai JM, Yin XY, Hou X, Hao XY, Cai JP,
Liang LJ and Zhang LJ: Analysis of the genome-wide DNA methylation
profile of side population cells in hepatocellular carcinoma. Dig
Dis Sci. 58:1934–1947. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Broadley KW, Hunn MK, Farrand KJ, Price
KM, Grasso C, Miller RJ, Hermans IF and McConnell MJ: Side
population is not necessary or sufficient for a cancer stem cell
phenotype in glioblastoma multiforme. Stem Cells. 29:452–461. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guo D, Xu BL, Zhang XH and Dong MM: Cancer
stem-like side population cells in the human nasopharyngeal
carcinoma cell line cne-2 possess epithelial mesenchymal transition
properties in association with metastasis. Oncol Rep. 28:241–247.
2012.PubMed/NCBI
|
|
42
|
Wei X, Dombkowski D, Meirelles K,
Pieretti-Vanmarcke R, Szotek PP, Chang HL, Preffer FI, Mueller PR,
Teixeira J, MacLaughlin DT and Donahoe PK: Mullerian inhibiting
substance preferentially inhibits stem/progenitors in human ovarian
cancer cell lines compared with chemotherapeutics. Proc Natl Acad
Sci USA. 107:18874–18879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu CP, Zhou L, Xie M, Du HD, Tian J, Sun S
and Li JY: Identification of cancer stem-like side population cells
in purified primary cultured human laryngeal squamous cell
carcinoma epithelia. PLoS One. 8:e657502013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tabor MH, Clay MR, Owen JH, Bradford CR,
Carey TE, Wolf GT and Prince ME: Head and neck cancer stem cells:
The side population. Laryngoscope. 121:527–533. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mack B and Gires O: CD44s and CD44v6
expression in head and neck epithelia. PLoS One. 3:e33602008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Keramari M, Razavi J, Ingman KA, Patsch C,
Edenhofer F, Ward CM and Kimber SJ: SOX2 is essential for formation
of trophectoderm in the preimplantation embryo. PLoS One.
5:e139522010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Okumura-Nakanishi S, Saito M, Niwa H and
Ishikawa F: Oct-3/4 and SOX2 regulate Oct-3/4 gene in embryonic
stem cells. J Biol Chem. 280:5307–5317. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Evans RD, Perkins VC, Henry A, Stephens
PE, Robinson MK and Watt FM: A tumor-associated beta 1 integrin
mutation that abrogates epithelial dfferentiation control. J Cell
Biol. 160:589–596. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yin AH, Miraglia S, Zanjani ED,
Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J and Buck
DW: AC133, a novel marker for human hematopoietic stem and
progenitor cells. Blood. 90:5002–5012. 1997.PubMed/NCBI
|
|
50
|
Aruffo A, Stamenkovic I, Melnick M,
Underhill CB and Seed B: CD44 is the principal cell surface
receptor for hyaluronate. Cell. 61:1303–1313. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Felthaus O, Ettl T, Gosau M, Driemel O,
Brockhoff G, Reck A, Zeitler K, Hautmann M, Reichert TE, Schmalz G
and Morsczeck C: Cancer stem cell-like cells from a single cell of
oral squamous carcinoma cell lines. Biochem Biophys Res Commun.
407:28–33. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Faber A, Barth C, Hörmann K, Kassner S,
Schultz JD, Sommer U, Stern-Straeter J, Thorn C and Goessler UR:
CD44 as a stem cell marker in head and neck squamous cell
carcinoma. Oncol Rep. 26:321–326. 2011.PubMed/NCBI
|
|
53
|
Oliveira LR, Oliveira-Costa JP, Araujo IM,
Soave DF, Zanetti JS, Soares FA, Zucoloto S and Ribeiro-Silva A:
Cancer stem cell immunophenotypes in oral squamous cell carcinoma.
J Oral Pathol Med. 40:135–142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Grimm M, Alexander D, Munz A, Hoffmann J
and Reinert S: Is 1,25-dihydroxyvitamin D3 receptor expression a
potential Achilles' heel of CD44+ oral squamous cell
carcinoma cells? Target Oncol. 8:189–201. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Nishikawa S, Konno M, Hamabe A, Hasegawa
S, Kano Y, Ohta K, Fukusumi T, Sakai D, Kudo T, Haraguchi N, et al:
Aldehyde dehydrogenase high gastric cancer stem cells are resistant
to chemotherapy. Int J Oncol. 42:1437–1442. 2013.PubMed/NCBI
|
|
56
|
Clay MR, Tabor M, Owen JH, Carey TE,
Bradford CR, Wolf GT, Wicha MS and Prince ME: Single-marker
identification of head and neck squamous cell carcinoma cancer stem
cells with aldehyde dehydrogenase. Head Neck. 32:1195–1201. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Krishnamurthy S, Dong Z, Vodopyanov D,
Imai A, Helman JI, Prince ME, Wicha MS and Nör JE: Endothelial
cell-initiated signaling promotes the survival and self-renewal of
cancer stem cells. Cancer Res. 70:9969–9978. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang Z, Dong Z, Lauxen IS, Filho MS and
Nör JE: Endothelial cell-secreted EGF induces epithelial to
mesenchymal transition and endows head and neck cancer cells with
stem-like phenotype. Cancer Res. 74:2869–2881. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Richard V and Pillai MR: The stem cell
code in oral epithelial tumorigenesis: 'The cancer stem cell shift
hypothesis'. Biochim Biophys Acta. 1806:146–162. 2010.PubMed/NCBI
|
|
60
|
Allegra E, Trapasso S, Pisani D and Puzzo
L: The role of BMI1 as a biomarker of cancer stem cells in head and
neck cancer: A review. Oncology. 86:199–205. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhou ZT and Jiang WW: Cancer stem cell
model in oral squamous cell carcinoma. Curr Stem Cell Res Ther.
3:17–20. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hayashi S, Tanaka J, Okada S, Isobe T,
Yamamoto G, Yasuhara R, Irie T, Akiyama C, Kohno Y, Tachikawa T and
Mishima K: Lin28a is a putative factor in regulating cancer stem
cell-like properties in side population cells of oral squamous cell
carcinoma. Exp Cell Res. 319:1220–1228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Miranda-Lorenzo I, Dorado J, Lonardo E,
Alcala S, Serrano AG, Clausell-Tormos J, Cioffi M, Megias D,
Zagorac S, Balic A, et al: Intracellular autofluorescence: A
biomarker for epithelial cancer stem cells. Nat Methods.
11:1161–1169. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kokalj Vokač N, Cizmarević B, Zagorac A,
Zagradišnik B and Lanišnik B: An evaluation of SOX2 and hTERC gene
amplifications as screening markers in oral and oropharyngeal
squamous cell carcinomas. Mol Cytogenet. 7:52014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
He KF, Zhang L, Huang CF, Ma SR, Wang YF,
Wang WM, Zhao ZL, Liu B, Zhao YF, Zhang WF and Sun ZJ:
CD163+ tumor-associated macrophages correlated with poor
prognosis and cancer stem cells in oral squamous cell carcinoma.
Biomed Res Int. 2014:8386322014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Chen C, Wei Y, Hummel M, Hoffmann TK,
Gross M, Kaufmann AM and Albers AE: Evidence for
epithelial-mesenchymal transition in cancer stem cells of head and
neck squamous cell carcinoma. PLoS One. 6:e164662011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Piao L, Zhang M, Datta J, Xie X, Su T, Li
H, Teknos TN and Pan Q: Lipid-based nanoparticle delivery of
Pre-miR-107 inhibits the tumorigenicity of head and neck squamous
cell carcinoma. Mol Ther. 20:1261–1269. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Walter V, Yin X, Wilkerson MD, Cabanski
CR, Zhao N, Du Y, Ang MK, Hayward MC, Salazar AH, Hoadley KA, et
al: Correction: Molecular subtypes in head and neck cancer exhibit
distinct patterns of chromosomal gain and loss of canonical cancer
genes. PLoS One. 8:e568232014. View Article : Google Scholar
|
|
69
|
Wilbertz T, Wagner P, Petersen K, Stiedl
AC, Scheble VJ, Maier S, Reischl M, Mikut R, Altorki NK, Moch H, et
al: SOX2 gene amplification and protein overexpression are
associated with better outcome in squamous cell lung cancer. Mod
Pathol. 24:944–953. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Hussenet T, Dali S, Exinger J, et al: SOX2
is an oncogene activated by recurrent 3q26.3 amplifications in
human lung squamous cell carcinomas. PLoS One. 5:e89602010.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Rodriguez-Pinilla SM, Sarrio D,
Moreno-Bueno G, Rodriguez-Gil Y, Martinez MA, Hernandez L,
Hardisson D, Reis-Filho JS and Palacios J: Sox2: A possible driver
of the basal-like phenotype in sporadic breast cancer. Mod Pathol.
20:474–481. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lu W, Feng F, Xu J, et al: QKI impairs
self-renewal and tumorigenicity of oral cancer cells via repression
of SOX2. Cancer Biol Ther. 15:1174–1184. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Hägerstrand D, He X, Bradic Lindh M, Hoefs
S, Hesselager G, Ostman A and Nistér M: Identification of a
SOX2-dependent subset of tumor - and sphere-forming glioblastoma
cells with a distinct tyrosine kinase inhibitor sensitivity
profile. Neuro Oncol. 13:1178–1191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Bourguignon LY, Wong G, Earle C and Chen
L: Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes
miR-302 expression leading to self-renewal, clonal formation, and
cisplatin resistance in cancer stem cells from head and neck
squamous cell carcinoma. J Biol Chem. 287:32800–32824. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Leis O, Eguiara A, Lopez-Arribillaga E,
Alberdi MJ, Hernandez-Garcia S, Elorriaga K, Pandiella A, Rezola R
and Martin AG: SOX2 expression in breast tumours and activation in
breast cancer stem cells. Oncogene. 31:1354–1365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Lim YC, Kang HJ, Kim YS and Choi EC:
All-trans-retinoic acid inhibits growth of head and neck cancer
stem cells by suppression of Wnt/β-catenin pathway. Eur J Cancer.
48:3310–3318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Sun Y, Han J, Lu Y, Yang X and Fan M:
Biological characteristics of a cell subpopulation in tongue
squamous cell carcinoma. Oral Dis. 18:169–177. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Lee SH, Nam HJ, Kang HJ, Kwon HW and Lim
YC: Epigallocatechin-3-gallate attenuates head and neck cancer stem
cell traits through suppression of Notch pathway. Eur J Cancer.
49:3210–3218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Züllig L, Roessle M, Weber C, Graf N,
Haerle SK, Jochum W, Stoeckli SJ, Moch H and Huber GF: High sex
determining region Y-box 2 expression is a negative predictor of
occult lymph node metastasis in early squamous cell carcinomas of
the oral cavity. Eur J Cancer. 49:1915–1922. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Xu N, Papagiannakopoulos T, Pan G, Thomson
JA and Kosik KS: MicroRNA-145 regulates OCT4, SOX2, and KLF4 and
represses pluripotency in human embryonic stem cells. Cell.
137:647–658. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Liu T, Cheng W, Huang Y, Huang Q, Jiang L
and Guo L: Human amniotic epithelial cell feeder layers maintain
human iPS cell pluripotency via inhibited endogenous microRNA-145
and increased SOX2 expression. Exp Cell Res. 318:424–434. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Huang CF, Xu XR, Wu TF, Sun ZJ and Zhang
WF: Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous
cell carcinoma and their association with disease progression and
prognosis. J Oral Pathol Med. 43:492–498. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Liu K, Lin B, Zhao M, Yang X, Chen M, Gao
A, Liu F, Que J and Lan X: The multiple roles for SOX2 in stem cell
maintenance and tumorigenesis. Cell Signal. 25:1264–1271. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Floor SL, Dumont JE, Maenhaut C and Raspe
E: Hallmarks of cancer: Of all cancer cells, all the time? Trends
Mol Med. 18:509–515. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Langley RR and Fidler IJ: The seed and
soil hypothesis revisited - the role of tumor-stroma interactions
in metastasis to different organs. Int J Cancer. 128:2527–2535.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Comen EA: Tracking the seed and tending
the soil: Evolving concepts in metastatic breast cancer. Discov
Med. 14:97–104. 2012.PubMed/NCBI
|
|
88
|
Comen E, Norton L and Massagué J: Clinical
implications of cancer self-seeding. Nat Rev Clin Oncol. 8:369–377.
2011.PubMed/NCBI
|
|
89
|
Nakatsugawa M, Takahashi A, Hirohashi Y,
Torigoe T, Inoda S, Murase M, Asanuma H, Tamura Y, Morita R,
Michifuri Y, et al: SOX2 is overexpressed in stem-like cells of
human lung adenocarcinoma and augments the tumorigenicity. Lab
Invest. 91:1796–1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lee HJ, Eom DW, Kang GH, Han SH, Cheon GJ,
Oh HS, Han KH, Ahn HJ, Jang HJ and Han MS: Colorectal
micropapillary carcinomas are associated with poor prognosis and
enriched in markers of stem cells. Mod Pathol. 26:1123–1131. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Hu H, Chang DT, Nikiforova MN, Kuan SF and
Pai RK: Clinicopathologic features of synchronous colorectal
carcinoma: A distinct subset arising from multiple sessile serrated
adenomas and associated with high levels of microsatellite
instability and favorable prognosis. Am J Surg Pathol.
37:1660–1670. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Han X, Fang X, Lou X, Hua D, Ding W, Foltz
G, Hood L, Yuan Y and Lin B: Silencing SOX2 induced
mesenchymal-epithelial transition and its expression predicts liver
and lymph node metastasis of CRC patients. PLoS One. 7:e413352012.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Abd El-Maqsoud NM and Abd El-Rehim DM:
Clinicopathologic implications of EpCAM and SOX2 expression in
breast cancer. Clin Breast Cancer. 14:e1–e9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Li X, Xu Y, Chen Y, Chen S, Jia X, Sun T,
Liu Y, Li X, Xiang R and Li N: SOX2 promotes tumor metastasis by
stimulating epithelial-to-mesenchymal transition via regulation of
WNT/β-catenin signal network. Cancer Lett. 336:379–389. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Li X, Chen S, Sun T, Xu Y, Chen Y, Liu Y,
Xiang R and Li N: The transcriptional regulation of SOX2 on FOXA1
gene and its application in diagnosis of human breast and lung
cancers. Clin Lab. 60:909–918. 2014.PubMed/NCBI
|
|
96
|
Yang F, Gao Y, Geng J, Qu D, Han Q, Qi J
and Chen G: Elevated expression of SOX2 and FGFR1 in correlation
with poor prognosis in patients with small cell lung cancer. Int J
Clin Exp Pathol. 6:2846–2854. 2013.PubMed/NCBI
|
|
97
|
Tang XB, Shen XH, Li L, Zhang YF and Chen
GQ: SOX2 overexpression correlates with poor prognosis in laryngeal
squamous cell carcinoma. Auris Nasus Larynx. 40:481–486. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Schröck A, Göke F, Wagner P, Bode M,
Franzen A, Braun M, Huss S, Agaimy A, Ihrler S, Menon R, et al: Sex
determining region Y-box 2 (SOX2) amplification is an independent
indicator of disease recurrence in sinonasal cancer. PLoS One.
8:e592012013. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
González-Márquez R, Llorente JL, Rodrigo
JP, García-Pedrero JM, Álvarez-Marcos C, Suárez C and Hermsen MA:
SOX2 expression in hypopharyngeal, laryngeal, and sinonasal
squamous cell carcinoma. Hum Pathol. 45:851–857. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Qiao B, He B, Cai J and Yang W: The
expression profile of Oct4 and SOX2 in the carcinogenesis of oral
mucosa. Int J Clin Exp Pathol. 7:28–37. 2014.PubMed/NCBI
|
|
101
|
Lu Y, Futtner C, Rock JR, Xu X, Whitworth
W, Hogan BL and Onaitis MW: Evidence that SOX2 overexpression is
oncogenic in the lung. PLoS One. 5:e110222010. View Article : Google Scholar : PubMed/NCBI
|
